Full Breakfast Buffet provided for Short Course attendees.
700
1800
Registration Desk Open
Location: Serra Foyer
800
1200
Short Course : LC-MSMS 101 : Getting Started with Quantitative LC-MSMS in the Diagnostic Laboratory
Location: De Anza 3
800
1200
Short Course : LC-MSMS 201 : LC-MSMS Technology and Techniques in the Clinical Lab
Location: De Anza 1
Robert Voyksner, PhD LCMS Limited
Dr. Robert D. Voyksner received his B.S. in Chemistry at Canisius College in 1978 and his Ph.D. at the University of North Carolina at Chapel Hill in 1982. He was employed at Research Triangle Institute (RTI) from 1983-2001 as the director of the mass spectrometry facility and has been responsible for developing
extraction, separation and mass spectrometric methods for biologically and environmentally significant compounds. His work earned him the Presidents Award, the highest award within RTI. In 2001 he co-founded LCMS Limited in Durham, NC and has been the CEO of the company to date. Under his direction LCMS Limited is working on technological advancements in LC-MS/MS, offering services to pharmaceutical, clinical and agrochemical industry for solving unique problems by LC/MS/MS and offering training in LC/MS/MS and MS/MS interpretation and on LC/MS/MS instrumentation. Dr Voyksner is also an Adjunct professor at the North Carolina a School of Veterinary Medicine and at The University of North Carolina
School of Pharmacy.
Dr. Voyksner's research in mass spectrometry has resulted in over 230 publications and presentations, primarily in the area of LC-MS/MS. He has served on the Board of Directors for The American Society For Mass Spectrometry (ASMS), is on the organization committee for The Montreux LC/MS Symposium and was the organizer for the 1995, 1999, 2003 and 2007 Montreux LC/MS Symposia. Dr. Voyksner has taught over 100 courses on LC-MSMS, CE/MS and CID interpretation during the past 10 years for MSACL, ASMS, pharmaceutical companies; ISSX, PBA, HPCE and HPLC focused meetings.
Relevant Financial Disclosures
(within past 24 months, reported on Jan 14, 2026)
Short Course : Data Science 101 : Breaking up with Excel: An Introduction to the R Statistical Programming Language
Location: Steinbeck 1
Daniel Holmes, MD, FRCPC St. Paul’s Hospital
Daniel Holmes did his undergraduate training in Chemistry and Physics at the University of Toronto before deciding to pursue medicine as a career. He attended medical school at the University of British Columbia where pathology became his area of major interest. The strong influence of his academic mentors led him to enter the Medical Biochemistry residency training program at UBC. This allowed him to use his background knowledge of chemistry in application to medicine. Areas of clinical interest are diagnostic lipidology/endocrinology and research interests are in the utilization of mathematics and computer diagnostics to laboratory medicine.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Dustin R. Bunch, is an Asst. Director of Clinical Chemistry & Co-Director Laboratory Informatics at Nationwide Children's Hospital. His research focuses small molecule analysis by mass spectrometry in a clinical setting and clinical informatics.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 13, 2024)
Not yet reported.
800
1200
Short Course : Sample Prep 201 : Sample Preparation and Alternative Matrices for LC-MS Assays
Location: De Anza 2
William Clarke, PhD, MBA, DABCC Johns Hopkins University School of Medicine
Dr. Clarke received his Ph.D. in Analytical Chemistry from the University of Nebraska in Lincoln in 2000, followed by a post-doctoral fellowship in Clinical Chemistry at the Johns Hopkins School of Medicine, ending in 2002. In addition, he received an MBA focused on medical services management from the Carey School of Business at Johns Hopkins in 2007. Following his post-doctoral fellowship, he remained at Johns Hopkins, where he is a Professor in the Department of Pathology, as well as the director of Point-of-Care Testing, Reference Toxicology, and Phlebotomy for the hospital. He also serves as the Vice-Chair for Quality and Regulatory Affairs in the Department of Pathology. His research interests include clinical mass spectrometry, method development and evaluation for therapeutic drug monitoring, clinical toxicology, point-of-care testing, and development/validation of biomarkers for use in drug management. Dr. Clarke has published as author or co-author over 170 peer-reviewed manuscripts or book chapters, and is the Co-Editor of the textbook Contemporary Practice in Clinical Chemistry.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Consultant Fees
Roche
Grant/Research Support
Thermo Fisher, Danaher, Roche
Committee/Board/Advisory Board
Roche, Truvian
Mark Marzinke, PhD, DABCC, FAACC Johns Hopkins University School of Medicine
Dr. Mark Marzinke is Professor of Pathology and Medicine in the Johns Hopkins University School of Medicine. He is board-certified in Clinical Chemistry by the American Board of Clinical Chemistry. He serves as the Director of the General Chemistry Laboratory at the Johns Hopkins Hospital and the Clinical Pharmacology Analytical Laboratory within the Division of Clinical Pharmacology. Dr. Marzinke is Co-Principal Investigator (PI) of the HIV Prevention Trials Network (HPTN) Laboratory Center (LC) and is the Director of the Clinical Laboratory Core for the Johns Hopkins Center for AIDS Research. His primary research interests are in the areas of antiretroviral pharmacology, HIV prevention science, mass spectrometry, pharmacogenetics and precision medicine, and laboratory automation. Dr. Marzinke has an active research program and serves as a principal investigator (PI) or co-investigator on a number of grants. He has collaborated on research to better characterize the multi-compartment pharmacology of antiretroviral agents when administered using alternative drug delivery systems using liquid chromatographic-mass spectrometric approaches. He has published more than 180 peer-reviewed articles, and holds leadership positions in several societies.
Relevant Financial Disclosures
(within past 24 months, reported on Mar 06, 2026)
No relevant financial relationship(s) to disclose.
800
1200
Short Course : Clinical Proteomics 201 : Clinical Proteomics
Location: Steinbeck 3
Andy Hoofnagle, MD, PhD University of Washington
Dr. Hoofnagle's laboratory focuses on the precise quantification of recognized protein biomarkers in human plasma using LC-MRM/MS. In addition, they have worked to develop novel assays for the quantification of small molecules in clinical and research settings. His laboratory also studies the role that the systemic inflammation plays in the pathophysiology of obesity, diabetes, and cardiovascular disease.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Grant/Research Support
Waters, Inc.
Christopher Shuford, PhD Labcorp
Chris Shuford, Ph.D., is Associate Vice President and Technical Director for research and development at Laboratory Corporation of America in Burlington, North Carolina. Chris received his B.S. in Chemistry & Physics at Longwood University and obtained his Ph.D. in Bioanalytical Chemistry from North Carolina State University under the tutelage of Professor David Muddiman, where his research focused on applications of nano-flow chromatography for multiplexed peptide quantification using protein cleavage coupled with isotope dilution mass spectrometry (PC-IDMS). In 2012, Chris joined LabCorp’s research and development team where his efforts have focused on development of high-flow chromatographic methods (>1 mL/min) for multiplexed and single protein assays for clinical diagnostics.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Stock/Bonds
Laboratory Corporation of America
Salary
Laboratory Corporation of America
Cory Bystrom, PhD Ultragenyx
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Stock/Bonds
Ultragenyx
Salary
Ultragenyx
800
1200
Short Course : GlycoProteomics 101 : Clinical glyco(proteo)mics by mass spectrometry
Location: Stevenson 2
Noortje de Haan, PhD University of Copenhagen
Noortje is conducting her post-doctoral research at the Copenhagen Center for Glycomics at the University of Copenhagen, Denmark. Here, she aims to identify tissue glycans that are involved in disease initiation and progression. Previously, she worked as postdoc at the Center for Proteomics and Metabolomics at the Leiden University Medical Center, The Netherlands, where she received her PhD in 2019 on the development and application of mass spectrometry-based methods for the analysis of (antibody) glycosylation. Noortje’s enthusiasm for glycoproteomic-related research started early in her scientific career and this remains a key drive in her current work. She is interested in the development of mass spectrometric methods and data analysis protocols for addressing clinical research questions.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 25, 2023)
Not yet reported.
Constantin Blöchl, PhD Center for Proteomics and Metabolomics, Leiden University Medical Center, The Netherlands
Constantin Blöchl obtained his PhD in Biochemistry at the University of Salzburg, Austria, where he focused on mass spectrometry-driven (glyc)omics approaches to understand dysregulated pathways in cancer. In 2022, he joined the Center for Proteomics and Metabolomics at the Leiden University Medical Center, the Netherlands as a post-doctoral researcher. He is dedicated to the development and implementation of novel analytical methods to capture the vast heterogeneity of antibody glyco- and proteoforms present in the human body. The assessment of clinically relevant structural and functional characteristics of pathological antibodies, for instance in autoimmune diseases, is at the center of his work.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 20, 2023)
Not yet reported.
1200
1330
Lunch
Location: Off-site
Short Course attendees receive complimentary lunch at Dustbowl Brewery. Receive voucher from instructor or at registration desk.
Short Course : LC-MSMS 101 : Getting Started with Quantitative LC-MSMS in the Diagnostic Laboratory
Location: De Anza 3
1330
1730
Short Course : Data Science 101 : Breaking up with Excel: An Introduction to the R Statistical Programming Language
Location: Steinbeck 1
1330
1730
Short Course : Data Science 201 : Flexing with R : Databases to Dashboards
Location: Colton
Shannon Haymond, PhD Northwestern University Feinberg School of Medicine
My lab performs research and clinical testing using mass spectrometry methods, develops new assays, and applies data analytics to enable improved quality and efficiency. My computational pathology efforts are aimed at building the capacity for advanced data analytics in the department through innovations in infrastructure, education, and research to facilitate data-informed decision making for clinical care, operations, and quality assurance.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Committee/Board/Advisory Board
Roche Diagnostics (ended)
Patrick Mathias, MD, PhD University of Washington
Patrick Mathias, M.D., Ph.D., is a board-certified clinical pathologist and Associate Director of Informatics for UW Laboratory Medicine.
Lab medicine has large impact on the general practice of medicine. It is key to correctly diagnosing diseases and selecting the right treatments for patients. Dr. Mathias's goal is to combine technical and medical knowledge to fulfill the triple aim--reduce the per capita cost of health care, improve the health of populations and most importantly improve the patient experience of care.
Dr. Mathias earned his M.D. and Ph.D. from the University of Illinois. His clinical and research interests include clinical informatics, clinical chemistry and molecular diagnostics.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Stock/Bonds
Amgen, Corcept Therapeutics, Monte Rosa Therapeutics
1330
1730
Short Course : Sample Prep 201 : Sample Preparation and Alternative Matrices for LC-MS Assays
Location: De Anza 2
1330
1730
Short Course : Clinical Proteomics 201 : Clinical Proteomics
Location: Steinbeck 3
1330
1730
Short Course : Metabolomics 201 : Measuring Metabolism from Dried Blood Spots to Microsampling and more
Location: Steinbeck 2
Tim Garrett, PhD University of Florida College of Medicine
Dr. Garrett has over 20 years of experience in the field of mass spectrometry spanning both instrument and application development. He received his PhD from the University of Florida, under Dr. Richard A. Yost, working on the first imaging mass spectrometry-based ion trap instrument. He has also developed MALDI-based approaches to analyze proteins in bacteria and small molecules in tissue specimens. His current interests include development of techniques and instrumentation for metabolomics science using LC-HRMS and translational work in diagnostics for dried blood spots. He is an Associate Professor in the Department of Pathology at the University of Florida, and Director for the Southeast Center for Integrated Metabolomics (SECIM).
Relevant Financial Disclosures
(within past 24 months, reported on Sep 11, 2025)
No relevant financial relationship(s) to disclose.
Donald Chace, PhD, MSFS, FACB Capitainer
Donald H. Chace, PhD, MSFS, FAACC is the Senior Application and Product Specialist for Capitainer. He is one of the primary developers of newborn metabolic screening using tandem Mass Spectrometry. Developed 25 years ago with the first screening publication in Clinical Chemistry that describes the MS-based newborn screening of PKU, the method is now used to screen millions of infants per year, worldwide. Dr. Chace is an expert in metabolism and clinical chemistry using mass spectrometry as well as microsample analysis, e.g. the dried blood spot. He has published 100 peer reviewed articles and has presented at numerous conferences that focus on areas in Neonatology, Clinical Chemistry, Newborn Screening, Mass Spectrometry and Forensic Science. Dr. Chace is a guest researcher in the newborn screening and molecular biology division at the CDC and recently joined mQACC.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 13, 2024)
Salary
Capitainer
1330
1730
Short Course : GlycoProteomics 101 : Clinical glyco(proteo)mics by mass spectrometry
Location: Stevenson 2
1330
1730
Short Course : LC-MSMS 201 : LC-MSMS Technology and Techniques in the Clinical Lab
